Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26.

Slides:



Advertisements
Similar presentations
Apoptosis By Douglas R. Green
Advertisements

Professor Robin Leatherbarrow Head of Biological Chemistry Department of Chemistry.
Mechanisms of Bcl-2 in Programmed Cell Death Laura Beth Hill St. Edward’s University.
Mechanisms of Bcl-2 in Programmed Cell Death Laura Beth Hill St. Edward’s University.
Apoptosis “Falling or dropping off”. Ughhhh…..
Amino Acids and Proteins 1.What is an amino acid / protein 2.Where are they found 3.Properties of the amino acids 4.How are proteins synthesized 1.Transcription.
Figure 16.45a The Biology of Cancer (© Garland Science 2007)
Ensemble Results of PIM1 PIM PIM Ensemble Results of GSK3 GSK GSK GSK
Enhancing the C-48 STAT3 Inhibitor
Mechanisms of Apoptosis/Review Ribozyme Inhibition of Bcl-2 Expression/Summary Sandra A. Gibson Hudson Ph.D.
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Drugs on the Brain Emma Robinson RCUK Academic Fellow.
Systems of Life systems biology Database services.
The Bh3 Domain of Puma: Structure Determination and Small Molecular Inhibitor Design Nicki Zevola Bahar Lab Lab Meeting March 25, 2009.
Bcl-2 family There are three classes of Bcl-2 according to their domains and apoptotic effect: – Anti-apoptotic proteins contain four specific domains.
1 vFLIP-IKK  Blocker Helix Mimetic Edith Chan WIBR.
Sam Klingbeil, Nicole Reiff and James Wagner.  ERK2 is part of a signaling cascade that results in neuronal differentation, mitogenesis, oncogenic transformation.
On the nature of cavities on protein surfaces: Application to the Identification of drug-binding sites Murad Nayal, Barry Honig Columbia University, NY.
Mount Mary College Students: Jessica Benson, Amy Ramirez, Nerissa Seward Faculty Advisor: Dr. Colleen Conway Medical College of Wisconsin Research Mentor:
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
1 Protein synthesis How a nucleotide sequence is translated into amino acids.
Proteins.
Purposes Of Apoptosis Eliminate cells not needed by organism During development: sculpting, remove excess neurons Adult –Maintain tissue size –Eliminate.
Cell death vs Cell life. Characteristic morphologic features of apoptosis Extr signal Intr signal nucleus DNA fragmentation (formation of nucleosomal.
Lesson 5 Enzymes. Catalyst: something that increases the rate of reactions Enzymes are biological catalysts Often ends with –ase Most enzymes are proteins.
HP-SEE In the search of the HDAC-1 inhibitors. The preliminary results of ligand based virtual screening Ilija N. Cvijetić, Ivan O. Juranić,
Structural Bioinformatics Elodie Laine Master BIM-BMC Semester 3, Genomics of Microorganisms, UMR 7238, CNRS-UPMC e-documents:
APPLICATIONS OF ANIMAL CELL CULTURE
The Retinoblastoma Protein
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects  Chi Chen, Ah-Ng Tony Kong  Trends in Pharmacological.
Novel Transcription Factor Inhibitor as Treatment for Epithelial Cell Cancers John Bushweller, Department of Molecular Physiology and Biological Physics,
PI3K inhibition does not Effect the BH3 Profile of SW620 Cells
Serine Proteases A large group of enzymes that cleave amide bond
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Cathode (attracts (+) amino acids)
Inducing Angiogenesis
Enzymes are a special type of protein!
Figure 3.14A–D Protein structure (layer 1)
Model for mitosis‐induced apoptosis.
Apoptosis-based therapies for hematologic malignancies
The forces at work on proteins/ glutamic acid and valine
Figure 3 The cell cycle and the role of CDK4/6 inhibition
Haixu Tang School of Inforamtics
Fragment to lead (to drug) optimization
Bindings of oliver leaf extract (OLE) to HIV-1 fusion protein gp41 John Z.H. Zhang, Department of Chemistry, New York University Recent experimental study.
Volume 11, Issue 3, Pages (March 2007)
The Biology Behind BCL2 as a Target in Myeloma
Mechanisms of apoptosis and growth arrest by isothiocyanates.
Figure 1 Balance between proteasomal load and capacity
Regulator of the apoptotic pathway
Phosphopeptides identified harboring minimal binding motifs
How to Test an Assertion
Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate- Specific Antigen  Aaron M. LeBeau, Pratap Singh, John T. Isaacs,
AML Therapy: Wake Up the Guardian and Cut Loose the Executioners
Volume 26, Issue 1, Pages e4 (January 2018)
Chapter 18 Naturally Occurring Nitrogen-Containing Compounds
The Chemical Biology of Apoptosis
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Death receptor-mediated apoptosis and the liver
Volume 10, Issue 8, Pages (August 2003)
E. coli Dihydroorotate Dehydrogenase Reveals Structural and Functional Distinctions between Different Classes of Dihydroorotate Dehydrogenases  Sofie.
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Nina Svensen, Juan José Díaz-Mochón, Mark Bradley  Chemistry & Biology 
Solution Structure of a TBP–TAFII230 Complex
Alexander Kiani, Anjana Rao, Jose Aramburu  Immunity 
Phosphopeptides identified harboring minimal binding motifs
Jean-Claude Martinou, Richard J. Youle  Developmental Cell 
Insights from Free-Energy Calculations: Protein Conformational Equilibrium, Driving Forces, and Ligand-Binding Modes  Yu-ming M. Huang, Wei Chen, Michael J.
Insights into Programmed Cell Death through Structural Biology
Fig. 3 Organization of the active site of DHHC20.
Presentation transcript:

Structure-guided design of a selective BCL-X L inhibitor Structure-guided design of a selective BCL-X L inhibitor Tianlei Sun 2013/11/26

Why search for inhibitors of BCL-XL BCL-X L is anti-apoptotic protein. Enhancing apoptotic responses of cancer cells by inhibiting BCL-X L. Instead of inhibiting multiple anti- apoptotic BCL-2 family members, a BCL- X L –selective inhibitor would be expected to minimize the toxicity to normal tissues.

How they did High-throughput screen Fig.1 Compound 1a identified from the screen and close analog 1b

Fig.2 Two potential binding modes for 1b in the hydrophobic groove of BCL-XL.

Fig.3 Structure of compound2. Fig.4 binding mode of 2 in the BCL-X L hydrophobic groove Fig.5 interaction network between the benzothiazole moiety of 2 and Ser106, Asp107 and Leu108 in the P2 pocket.

Fig.6 Position of Phe105 in relation to the furan moiety of 2 and the electrostatic interaction between Arg139 and the acylsulfonamide group of 2.

Pymol 演示